Overview

A Feasibility Study of Gallium-68 Citrate PET to Detect Aberrant MYC Proto-Oncogene, BHLH Transcription Factor (MYC) Protein Expression in Diffuse Large B-Cell Lymphoma

Status:
Withdrawn
Trial end date:
2018-04-09
Target enrollment:
Participant gender:
Summary
This is a single center imaging study investigating the use of PET with 68Ga-citrate in patients with DLBCL or BCLU.
Phase:
Phase 2
Details
Lead Sponsor:
University of California, San Francisco
Treatments:
Citric Acid
Gallium citrate
Sodium Citrate